Year archive

ORTHOCELL LIMITED — 2025 filings

All 108 regulatory filings released by ORTHOCELL LIMITED (OCC) in 2025, sourced directly from the official regulator.

108 Filings

2025 Period

2025 filings (108)

Filing	Released	Lang
Application for quotation of securities - OCC 8 pages 21.7KB Regulatory Filings	2025-12-21	English
Cleansing Notice 2 pages 669.4KB Regulatory Filings	2025-12-21	English
Appendix 3Y - Paul Anderson 2 pages 226.2KB Regulatory Filings	2025-12-21	English
Orthocell Hits US Milestone - 100 Remplir Units Sold. 3 pages 682.1KB Regulatory Filings	2025-12-17	English
Remplir Regulatory Application for US$750m EU-UK Market 3 pages 667.1KB Regulatory Filings	2025-12-14	English
First Commercial Sales of Remplir Achieved in Hong Kong 3 pages 270.0KB Regulatory Filings	2025-12-09	English
Notification regarding unquoted securities - OCC 8 pages 22.4KB Regulatory Filings	2025-11-27	English
Appendix 3Y - Paul Anderson 2 pages 226.0KB Regulatory Filings	2025-11-27	English
Remplir gains momentum in nerve-sparing prostate surgery 4 pages 648.7KB Regulatory Filings	2025-11-19	English
Application for quotation of securities - OCC 8 pages 20.8KB Regulatory Filings	2025-11-13	English
Cleansing Notice 2 pages 670.8KB Regulatory Filings	2025-11-13	English
AGM Addresses by Chair and Managing Director 28 pages 2.4MB Regulatory Filings	2025-11-05	English
Results of Annual General Meeting 4 pages 669.7KB Regulatory Filings	2025-11-05	English
Amended Constitution 64 pages 1.5MB Regulatory Filings	2025-11-05	English
2nd Distributor in Canada, Entire $75m Market Now Covered 3 pages 652.6KB Regulatory Filings	2025-11-04	English
Remplir Launches in Hong Kong with First Surgical Case 3 pages 832.2KB Regulatory Filings	2025-11-02	English
Appendix 3Y - John Van Der Wielen 2 pages 218.8KB Regulatory Filings	2025-10-30	English
Appendix 3Y - Michael McNulty 2 pages 217.4KB Regulatory Filings	2025-10-30	English
HK Distributor Signed as Remplir Expands in the Asian Market 3 pages 631.3KB Regulatory Filings	2025-10-28	English
Application for quotation of securities - OCC 8 pages 21.1KB Regulatory Filings	2025-10-23	English
Cleansing Notice 2 pages 670.4KB Regulatory Filings	2025-10-23	English
Notification regarding unquoted securities - OCC 10 pages 27.2KB Regulatory Filings	2025-10-23	English
Application for quotation of securities - OCC 8 pages 20.8KB Regulatory Filings	2025-10-20	English
Cleansing Notice 2 pages 669.6KB Regulatory Filings	2025-10-20	English
OCC Secures Rights to High-Value Bone Regeneration Tech 3 pages 306.8KB Regulatory Filings	2025-10-19	English
$30m Placement Sees Orthocell Positioned for Rapid Growth 4 pages 672.5KB Regulatory Filings	2025-10-16	English
Proposed issue of securities - OCC 7 pages 24.9KB Regulatory Filings	2025-10-16	English
Letter, Supplementary Notice of AGM & Replacement Proxy Form 16 pages 502.6KB Regulatory Filings	2025-10-16	English
Trading Halt 3 pages 802.9KB Regulatory Filings	2025-10-14	English
Quarterly Activity Report & Appendix 4C 8 pages 865.3KB Regulatory Filings	2025-10-09	English
Letter to Shareholders, Notice of AGM & Proxy Form 33 pages 732.9KB Regulatory Filings	2025-10-02	English
Annual Report to Shareholders 91 pages 10.8MB Regulatory Filings	2025-10-02	English
Another Record Revenue Quarter for Orthocell 4 pages 696.9KB Regulatory Filings	2025-10-01	English
First Distributor signed for Remplir in $75m Canadian Market 3 pages 643.6KB Regulatory Filings	2025-09-29	English
Application for quotation of securities - OCC 9 pages 23.9KB Regulatory Filings	2025-09-29	English
Cleansing Notice 2 pages 597.6KB Regulatory Filings	2025-09-29	English
Remplir Use in Prostate Surgery Signals Global Opportunity 4 pages 668.2KB Regulatory Filings	2025-09-15	English
Date of AGM & Closing Date for Director Nominations 2 pages 123.4KB Regulatory Filings	2025-09-09	English
Compelling 81% Success Rate for Remplir 4 pages 327.5KB Regulatory Filings	2025-09-07	English
Application for quotation of securities - OCC 8 pages 20.8KB Regulatory Filings	2025-09-02	English
Cleansing Notice 2 pages 169.0KB Regulatory Filings	2025-09-02	English
Initial Director's Interest Notice - Mr Michael McNulty 2 pages 194.2KB Regulatory Filings	2025-08-31	English
Notification regarding unquoted securities - OCC 8 pages 22.8KB Regulatory Filings	2025-08-31	English
Replacement Initial Director's Interest Notice 2 pages 195.4KB Regulatory Filings	2025-08-31	English
Appendix 4E & Annual Report 91 pages 10.9MB Regulatory Filings	2025-08-28	English
Corporate Governance Statement 13 pages 404.4KB Regulatory Filings	2025-08-28	English
Appendix 4G 11 pages 365.4KB Regulatory Filings	2025-08-28	English
Investor Presentation Canaccord Annual Growth Conference 22 pages 1.7MB Regulatory Filings	2025-08-14	English
Remplir Commericalisation into $1.6B US Market Gathers Pace 2 pages 200.4KB Regulatory Filings	2025-08-12	English
Proposed issue of securities - OCC 6 pages 22.1KB Regulatory Filings	2025-07-27	English
Option Terms and Conditions 4 pages 296.8KB Regulatory Filings	2025-07-27	English
Notification regarding unquoted securities - OCC 10 pages 27.1KB Regulatory Filings	2025-07-27	English
Orthocell Announces Changes to Board of Directors 5 pages 260.6KB Regulatory Filings	2025-07-24	English
Proposed issue of securities - OCC 5 pages 18.4KB Regulatory Filings	2025-07-24	English
Final Director's Interest Notice 2 pages 274.7KB Regulatory Filings	2025-07-24	English
Notification of cessation of securities - OCC 5 pages 16.2KB Regulatory Filings	2025-07-13	English
Orthocell Announces First US Remplir Sales Revenue 2 pages 229.6KB Regulatory Filings	2025-07-09	English
Application for quotation of securities - OCC 9 pages 23.7KB Regulatory Filings	2025-07-09	English
Cleansing Notice 2 pages 169.1KB Regulatory Filings	2025-07-09	English
Quarterly Activity Report & Appendix 4C 11 pages 540.0KB Regulatory Filings	2025-07-08	English
Orthocell Bolsters Leadership with Key Hires 3 pages 209.6KB Regulatory Filings	2025-07-01	English
Remplir US Rollout & 1st Surgery Investor Update 20 pages 1.6MB Regulatory Filings	2025-07-01	English
Record Revenue of $2.73m in June 25 Quarter up 22.8% QoQ 4 pages 351.3KB Regulatory Filings	2025-06-30	English
First Surgical Use of Remplir in US$1.6 Billion US Market 3 pages 231.8KB Regulatory Filings	2025-06-26	English
Investor Webinar 2 pages 218.0KB Regulatory Filings	2025-06-26	English
Compelling Data Highlights Remplir Competitive Advantage 4 pages 288.9KB Regulatory Filings	2025-06-18	English
Application for quotation of securities - OCC 9 pages 23.7KB Regulatory Filings	2025-06-09	English
Cleansing Notice 2 pages 169.3KB Regulatory Filings	2025-06-09	English
Remplir Approved to Commence Sales in the Hong Kong Market 3 pages 217.2KB Regulatory Filings	2025-05-11	English
12 Distributors Signed for Remplir Covering 21 States in US 3 pages 188.0KB Regulatory Filings	2025-05-08	English
Remplir Approved to Commence Sales in US$75m Canadian Market 3 pages 235.5KB Regulatory Filings	2025-04-29	English
Pause in Trading 1 page 114.8KB Regulatory Filings	2025-04-28	English
Trading Halt 3 pages 248.9KB Regulatory Filings	2025-04-28	English
Replacement Trading Halt 3 pages 249.2KB Regulatory Filings	2025-04-28	English
Remplir Approved to Commence Sales in US$84M Thai Market 3 pages 230.2KB Regulatory Filings	2025-04-27	English
First US Distributors Signed for Remplirs US$1.6B market 3 pages 172.4KB Regulatory Filings	2025-04-22	English
Quarterly Activity Report & Appendix 4C 10 pages 704.9KB Regulatory Filings	2025-04-13	English
Remplir Regulatory Application Submitted for Hong Kong 2 pages 186.8KB Regulatory Filings	2025-04-09	English
Regulatory Approval for Striate in US$65M Brazilian Market 3 pages 238.5KB Regulatory Filings	2025-04-08	English
Remplir Cleared to Commence Sales in US$1.6B US Market 3 pages 217.8KB Regulatory Filings	2025-04-03	English
Investor Presentation - US FDA 510(k) Clearance for Remplir 21 pages 1.9MB Regulatory Filings	2025-04-03	English
Orthocell Webinar Details - Remplir US FDA 510(k) Clearance 2 pages 200.6KB Regulatory Filings	2025-04-03	English
Trading Halt 3 pages 250.4KB Regulatory Filings	2025-04-02	English
Orthocell to Present at HealthInvest Summit 27 pages 2.9MB Regulatory Filings	2025-04-01	English
Application for quotation of securities - OCC 8 pages 21.0KB Regulatory Filings	2025-03-26	English
First Sales of Striate in Germany, Austria & Swiss Region 3 pages 194.7KB Regulatory Filings	2025-03-25	English
Regulatory approval to commence Striate sales in Singapore 3 pages 213.2KB Regulatory Filings	2025-03-17	English
Notification regarding unquoted securities - OCC 8 pages 20.6KB Regulatory Filings	2025-03-16	English
Notification regarding unquoted securities - OCC 10 pages 28.5KB Regulatory Filings	2025-03-03	English
Application for quotation of securities - OCC 8 pages 21.3KB Regulatory Filings	2025-03-02	English
Cleansing Notice 1 page 128.9KB Regulatory Filings	2025-03-02	English
Application for quotation of securities - OCC 8 pages 21.0KB Regulatory Filings	2025-02-27	English
Orthocell Webinar Presentation 24 pages 2.4MB Regulatory Filings	2025-02-25	English
Orthocell Webinar 2 pages 182.0KB Regulatory Filings	2025-02-24	English
Appendix 4D & Half-Year Financial Report 24 pages 4.4MB Regulatory Filings	2025-02-23	English
Remplir FDA Application submitted for US$84M Thai Market 3 pages 198.0KB Regulatory Filings	2025-02-20	English
Application for quotation of securities - OCC 10 pages 26.7KB Regulatory Filings	2025-02-17	English
Cleansing Notice 1 page 128.1KB Regulatory Filings	2025-02-17	English
Remplir Regulatory Application Submitted for Canada 3 pages 202.8KB Regulatory Filings	2025-02-02	English
Strong Sales Drives Acceleration of Remplir Global Expansion 3 pages 392.4KB Regulatory Filings	2025-01-21	English
Orthocell Receives $3.18 million R&D Tax Refund 2 pages 196.0KB Regulatory Filings	2025-01-19	English
Quarterly Activity Report & Appendix 4C 9 pages 731.9KB Regulatory Filings	2025-01-14	English
Proposed issue of securities - OCC 5 pages 18.5KB Regulatory Filings	2025-01-13	English
Option Terms and Conditions 3 pages 269.5KB Regulatory Filings	2025-01-13	English
Application for quotation of securities - OCC 8 pages 21.0KB Regulatory Filings	2025-01-13	English
Application for quotation of securities - OCC 8 pages 21.2KB Regulatory Filings	2025-01-13	English
Notification regarding unquoted securities - OCC 8 pages 22.8KB Regulatory Filings	2025-01-13	English
Third Consecutive Quarter of Record Revenue for Orthocell 3 pages 252.9KB Regulatory Filings	2025-01-07	English

Filings by year

2026 27 filings
2025 108 filings
2024 85 filings
2023 59 filings
2022 43 filings
2021 77 filings
2020 42 filings
2019 79 filings
2018 65 filings
2017 55 filings
2016 46 filings
2015 48 filings
2014 44 filings